Correlated Drug Terms (2)

---

	Name (Synonyms)	Correlation
drug1365	Lopinavir-Ritonavir Wiki	0.71
drug1086	Hydroxychloroquine Wiki	0.10

Correlated MeSH Terms (2)

---

	Name (Synonyms)	Correlation
D045169	Severe Acute Respiratory Syndrome NIH	0.05
D018352	Coronavirus Infections NIH	0.04

Correlated HPO Terms (0)

---

	Name (Synonyms)	Correlation

Primary Outcomes

Description: fever,cough and other symptoms relieved with improved lung CT; SPO2>93% or PaO2/FiO2 >300mmHg without oxygen inhalation.

Measure: Rate of disease remission

Time: 14 days

---

Description: Comply with any of the followings: Respiratory failure occurs and requires mechanical ventilation; Shock; Patients combined with other organ failure need ICU monitoring and treatment.

Measure: Rate of entering the critical stage

Time: 14 days

---

Description: Comply with any of the followings: Respiratory failure occurs and requires mechanical ventilation; Shock; Patients combined with other organ failure need ICU monitoring and treatment.

Measure: Time of entering the critical stage

Time: 14 days

---

Secondary Outcomes

Measure: Rate of no fever

Time: 14 days

---

Measure: Rate of respiratory symptom remission

Time: 14 days

---

Measure: Rate of lung imaging recovery

Time: 14 days

---

Measure: Rate of C-reactive protein (CRP) recovery

Time: 14 days

---

Measure: Rate of Biochemical criterion (CK, ALT, Mb) recovery

Time: 14 days

---

Measure: Rate of undetectable viral RNA (continuous twice)

Time: 14 days

---

Description: From the date of enrollment to the time when the subject is released from the hospital or transferred to the corresponding department for treatment of other diseases according to the condition.

Measure: Time for hospitalization

Time: 14 days

---

Description: All adverse events will be coded and described using the International Medical Terms Dictionary (MedDRA).

Measure: Rate of adverse event

Time: 14 days

---